Trials / Completed
CompletedNCT01645176
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
Hydroxychloroquine/Atorvastatin in the Treatment of OA of the Knee
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is to learn about the effects in inflammation and pain in patients with Osteoarthritis of the knee. These medications are FDA approved and commercially available.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydroxychloroquine/Atorvastatin | Hydroxychloroquine 200-600 mg /day Atorvastatin 40 mg/day |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2016-04-01
- Completion
- 2016-10-01
- First posted
- 2012-07-20
- Last updated
- 2018-07-13
- Results posted
- 2017-05-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01645176. Inclusion in this directory is not an endorsement.